Locked nucleic acid as a novel class of therapeutic agents
- PMID: 19458498
- DOI: 10.4161/rna.6.3.8807
Locked nucleic acid as a novel class of therapeutic agents
Abstract
Locked Nucleic Acid (LNA) is a nucleic acid analogue with unprecedented binding affinity and excellent specificity toward complementary RNA and DNA oligonucleotides. The remarkable properties of LNA have led to applications within various gene silencing strategies both in vitro and in vivo. In the present review, we highlight the uses of LNA for regulation of gene expression with emphasis on RNA targeting.
Similar articles
-
Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.Chem Biodivers. 2010 Mar;7(3):536-42. doi: 10.1002/cbdv.200900343. Chem Biodivers. 2010. PMID: 20232325 Review.
-
Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.Oligonucleotides. 2004;14(2):130-46. doi: 10.1089/1545457041526317. Oligonucleotides. 2004. PMID: 15294076 Review.
-
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.Biochemistry. 2004 Oct 26;43(42):13233-41. doi: 10.1021/bi0485732. Biochemistry. 2004. PMID: 15491130 Review.
-
Locked nucleic acid (LNA): A modern approach to cancer diagnosis and treatment.Exp Cell Res. 2023 Feb 1;423(1):113442. doi: 10.1016/j.yexcr.2022.113442. Epub 2022 Dec 12. Exp Cell Res. 2023. PMID: 36521777 Review.
-
LNA-antisense rivals siRNA for gene silencing.Curr Opin Drug Discov Devel. 2004 Mar;7(2):188-94. Curr Opin Drug Discov Devel. 2004. PMID: 15603252 Review.
Cited by
-
Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments.Cells. 2021 Mar 8;10(3):591. doi: 10.3390/cells10030591. Cells. 2021. PMID: 33800164 Free PMC article. Review.
-
PEI-complexed LNA antiseeds as miRNA inhibitors.RNA Biol. 2012 Aug;9(8):1088-98. doi: 10.4161/rna.21165. Epub 2012 Aug 1. RNA Biol. 2012. PMID: 22894918 Free PMC article.
-
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation.Cancers (Basel). 2021 Nov 5;13(21):5555. doi: 10.3390/cancers13215555. Cancers (Basel). 2021. PMID: 34771719 Free PMC article. Review.
-
Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.Antimicrob Agents Chemother. 2011 Jul;55(7):3105-14. doi: 10.1128/AAC.00222-11. Epub 2011 Apr 18. Antimicrob Agents Chemother. 2011. PMID: 21502629 Free PMC article.
-
Lipids and Lipid Derivatives for RNA Delivery.Chem Rev. 2021 Oct 27;121(20):12181-12277. doi: 10.1021/acs.chemrev.1c00244. Epub 2021 Jul 19. Chem Rev. 2021. PMID: 34279087 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources